Cost-effectiveness of telephonic disease management in heart failure

Objective: To evaluate the cost-effectiveness of a telephonic disease management (DM) intervention in heart failure (HF).

Study design: Randomized controlled trial of telephonic DM among 1069 community-dwelling patients with systolic HF (SHF) and diastolic HF performed between 1999 and 2003. The enrollment period was 18 months per subject.

Methods: Bootstrap-resampled incremental cost-effectiveness ratios (ICERs) were computed and compared across groups. Direct medical costs were obtained from a medical record review that collected records from 92% of patients; 66% of records requested were obtained.

Results: Disease management produced statistically significant survival advantages among all patients (17.4 days, P = .04), among patients with New York Heart Association (NYHA) class III/IV symptoms (47.7 days, P = .02), and among patients with SHF (24.2 days, P = .01). Analyses of direct medical and intervention costs showed no cost savings associated with the intervention. For all patients and considering all-cause medical care, the ICER was $146 870 per quality-adjusted life-year (QALY) gained, while for patients with NYHA class III/IV symptoms and patients with SHF, the ICERs were $67 784 and $95 721 per QALY gained, respectively. Costs per QALY gained were $101 120 for all patients, $72 501 for patients with SHF, and $41 348 for patients with NYHA class III/IV symptoms.

Conclusions: The intervention was effective but costly to implement and did not reduce utilization. It may not be cost-effective in other broadly representative samples of patients. However, with program cost reductions and proper targeting, this program may produce life-span increases at costs that are less than $100 000 per QALY gained.

Similar articles

Galbreath AD, Krasuski RA, Smith B, Stajduhar KC, Kwan MD, Ellis R, Freeman GL. Galbreath AD, et al. Circulation. 2004 Dec 7;110(23):3518-26. doi: 10.1161/01.CIR.0000148957.62328.89. Epub 2004 Nov 7. Circulation. 2004. PMID: 15531765 Clinical Trial.

Calvert MJ, Freemantle N, Yao G, Cleland JG, Billingham L, Daubert JC, Bryan S; CARE-HF investigators. Calvert MJ, et al. Eur Heart J. 2005 Dec;26(24):2681-8. doi: 10.1093/eurheartj/ehi662. Epub 2005 Nov 11. Eur Heart J. 2005. PMID: 16284203 Clinical Trial.

Miller G, Randolph S, Forkner E, Smith B, Galbreath AD. Miller G, et al. Med Decis Making. 2009 May-Jun;29(3):325-33. doi: 10.1177/0272989X08327494. Epub 2009 Jan 15. Med Decis Making. 2009. PMID: 19147835

Hutchinson J, Scott DA, Clegg AJ, Loveman E, Royle P, Bryant J, Colquitt JL. Hutchinson J, et al. Expert Rev Cardiovasc Ther. 2008 Feb;6(2):175-85. doi: 10.1586/14779072.6.2.175. Expert Rev Cardiovasc Ther. 2008. PMID: 18248272 Review.

Cited by

Zakiyah N, Marulin D, Alfaqeeh M, Puspitasari IM, Lestari K, Lim KK, Fox-Rushby J. Zakiyah N, et al. J Med Internet Res. 2024 Apr 30;26:e53500. doi: 10.2196/53500. J Med Internet Res. 2024. PMID: 38687991 Free PMC article.

Caillon M, Sabatier R, Legallois D, Courouve L, Donio V, Boudevin F, de Chalus T, Hauchard K, Belin A, Milliez P. Caillon M, et al. BMC Cardiovasc Disord. 2022 Oct 10;22(1):441. doi: 10.1186/s12872-022-02878-1. BMC Cardiovasc Disord. 2022. PMID: 36217130 Free PMC article.

González-Guerrero JL, Hernández-Mocholi MA, Ribera-Casado JM, García-Mayolín N, Alonso-Fernández T, Gusi N. González-Guerrero JL, et al. Eur Geriatr Med. 2018 Aug;9(4):523-532. doi: 10.1007/s41999-018-0074-y. Epub 2018 Jun 6. Eur Geriatr Med. 2018. PMID: 34674493

Boodoo C, Zhang Q, Ross HJ, Alba AC, Laporte A, Seto E. Boodoo C, et al. J Med Internet Res. 2020 Oct 6;22(10):e18917. doi: 10.2196/18917. J Med Internet Res. 2020. PMID: 33021485 Free PMC article.

Kalter-Leibovici O, Freimark D, Freedman LS, Kaufman G, Ziv A, Murad H, Benderly M, Silverman BG, Friedman N, Cukierman-Yaffe T, Asher E, Grupper A, Goldman D, Amitai M, Matetzky S, Shani M, Silber H; Israel Heart Failure Disease Management Study (IHF-DMS) investigators. Kalter-Leibovici O, et al. BMC Med. 2017 May 1;15(1):90. doi: 10.1186/s12916-017-0855-z. BMC Med. 2017. PMID: 28457231 Free PMC article. Clinical Trial.